Total: 2 |
|
PMID (PMCID) | ||
---|---|---|
16697747 |
FEMALE | Child |
Intestinal cholesterol absorption inhibitor ezetimibe added to cholestyramine for sitosterolemia and xanthomatosis. | ||
Salen G, Starc T, Sisk CM, Patel SB. Gastroenterology. 2006;130(6):1853-7. |
||
Sitosterolemia is a rare, recessively inherited disorder characterized by increased absorption and delayed removal of noncholesterol sterols, which is associated with accelerated atherosclerosis, premature coronary artery disease, hemolysis, and xanthomatosis. | ||
4067433 |
MIXED_SAMPLE | Adult |
Lethal atherosclerosis associated with abnormal plasma and tissue sterol composition in sitosterolemia with xanthomatosis. | ||
Salen G, Horak I, Rothkopf M, Cohen JL, Speck J, Tint GS, Shore V, Dayal B, Chen T, Shefer S. J Lipid Res. 1985;26(9):1126-33. |
||
These results indicate that cholesterol, plant sterols, and 5 alpha-stanols are deposited prematurely and are associated with accelerated atherosclerosis in subjects with sitosterolemia with xanthomatosis. |